Prevalence and Regional Differences of Diabetic Retinopathy in Sub-Saharan Africa: Insights from a Systematic Review and Meta-Analysis - Scorecard - MDSpire

Prevalence and Regional Differences of Diabetic Retinopathy in Sub-Saharan Africa: Insights from a Systematic Review and Meta-Analysis

  • By

  • Mohamed Farah Ismail

  • Intisar Khalafalla

  • Zakaria Omar Sheck

  • Sowda Abdikariim Shiekh Isse

  • Fathi Abdi Farah

  • Ibrahim Abdirahman Mohamed

  • Abdulkarim Ismail Qarbote

  • Abdikarim Ahmed Warsame

  • Naima Abdinour Salah

  • Amina Mohamed Mire

  • Bahja Ahmed Mumin

  • December 26, 2025

  • 0 min

Share

Clinical Scorecard: Prevalence and Regional Differences of Diabetic Retinopathy in Sub-Saharan Africa: Insights from a Systematic Review and Meta-Analysis

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationAdults (≥18 years) with diabetes in Sub-Saharan Africa.
Care Setting

Key Highlights

  • highlight_1

Guideline-Based Recommendations

Diagnosis

  • Diagnosis of DR should be conducted by ophthalmologist examination or fundus-photograph interpretation (reference needed).

Management

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Access to screening and treatment varies significantly across regions, with specific barriers such as cost and availability.

        Clinical Best Practices

        • practice_1

        References

        Original Source(s)

        Prevalence and Regional Differences of Diabetic Retinopathy in Sub-Saharan Africa: Insights from a Systematic Review and Meta-Analysis

        • by Mohamed Farah Ismail, Intisar Khalafalla, Zakaria Omar Sheck, Sowda Abdikariim Shiekh Isse, Fathi Abdi Farah, Ibrahim Abdirahman Mohamed, Abdulkarim Ismail Qarbote, Abdikarim Ahmed Warsame, Naima Abdinour Salah, Amina Mohamed Mire, Bahja Ahmed Mumin

        • December 26, 2025

        Related Content

        Update on Diabetic Disease

        Upfront: Monthly reflection by Editor in Chief Diana V. Do, MD.

        AACE 2026: AI moves from hype to reality in diabetes care

        "Right now, AI is more of a copilot, but the long-term vision is something much closer to autopilot."

        Comparative study of the therapeutic effects of different medications on DM-associated dry eye syndrome after vitrectomy